$GERN
GERON CORP

2018 Q1 Form 10-K Financial Statement

#000156459018006051 Filed on March 16, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q3
Revenue $318.0K $191.0K $163.0K
YoY Change -40.78% 103.19% -96.81%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.320M $5.450M $4.770M
YoY Change 14.16% 14.5% 2.14%
% of Gross Profit
Research & Development $2.440M $2.520M $2.640M
YoY Change -27.68% -38.83% -38.87%
% of Gross Profit
Depreciation & Amortization $16.00K $20.00K $20.00K
YoY Change -20.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $7.755M $7.977M $7.407M
YoY Change -3.44% -10.12% -17.56%
Operating Profit -$7.437M -$7.244M
YoY Change -0.76% 86.85%
Interest Expense $250.0K $360.0K $350.0K
YoY Change -19.35% 20.0% 16.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$7.190M -$7.430M -$6.900M
YoY Change 0.14% -12.38% 92.74%
Income Tax
% Of Pretax Income
Net Earnings -$7.186M -$7.429M -$6.899M
YoY Change 0.04% -12.41% 92.93%
Net Earnings / Revenue -2259.75% -3889.53% -4232.52%
Basic Earnings Per Share
Diluted Earnings Per Share -$44.79K -$46.63K -$43.34K
COMMON SHARES
Basic Shares Outstanding 160.7M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.80M $94.69M $96.90M
YoY Change -9.57% -17.52% -10.69%
Cash & Equivalents $7.912M $16.34M $10.17M
Short-Term Investments $81.90M $78.35M $87.00M
Other Short-Term Assets $800.0K $900.0K $1.200M
YoY Change -88.06% 12.5% 9.09%
Inventory
Prepaid Expenses $512.0K $580.0K
Receivables
Other Receivables
Total Short-Term Assets $91.13M $95.97M $98.60M
YoY Change -14.51% -17.35% -14.34%
LONG-TERM ASSETS
Property, Plant & Equipment $86.00K $102.0K $100.0K
YoY Change -57.0% -44.26% -50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $13.20M $14.20M $15.60M
YoY Change -40.27% 1.43% -25.71%
Other Assets $1.189M
YoY Change
Total Long-Term Assets $14.38M $14.34M $15.64M
YoY Change -35.21% 1.46% -25.86%
TOTAL ASSETS
Total Short-Term Assets $91.13M $95.97M $98.60M
Total Long-Term Assets $14.38M $14.34M $15.64M
Total Assets $105.5M $110.3M $114.2M
YoY Change -18.08% -15.31% -16.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $502.0K $503.0K $261.0K
YoY Change 67.33% 123.56% -13.0%
Accrued Expenses $3.900M $926.0K $1.112M
YoY Change -22.0% -35.43% -84.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.385M $6.516M $5.970M
YoY Change -62.2% -17.19% -18.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.385M $6.516M $5.970M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.400M $6.500M $6.000M
YoY Change -62.07% -17.72% -17.81%
SHAREHOLDERS EQUITY
Retained Earnings -$984.4M -$985.8M -$978.4M
YoY Change 2.91%
Common Stock $1.093B $1.090B $1.087B
YoY Change 0.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $101.1M $103.8M $108.3M
YoY Change
Total Liabilities & Shareholders Equity $105.5M $110.3M $114.2M
YoY Change -18.08% -15.31% -16.12%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$7.186M -$7.429M -$6.899M
YoY Change 0.04% -12.41% 92.93%
Depreciation, Depletion And Amortization $16.00K $20.00K $20.00K
YoY Change -20.0% 0.0% 0.0%
Cash From Operating Activities -$7.368M -$4.390M -$4.420M
YoY Change 0.83% 631.67% -32.62%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$2.610M $9.740M $7.730M
YoY Change -127.88% 29.01% 86.27%
Cash From Investing Activities -$2.608M $9.740M $7.730M
YoY Change -127.87% 29.69% 86.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.553M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.553M 1.070M 0.000
YoY Change 10600.0% -100.0%
NET CHANGE
Cash From Operating Activities -7.368M -4.390M -4.420M
Cash From Investing Activities -2.608M 9.740M 7.730M
Cash From Financing Activities 1.553M 1.070M 0.000
Net Change In Cash -8.423M 6.420M 3.310M
YoY Change -510.68% -7.23% -242.67%
FREE CASH FLOW
Cash From Operating Activities -$7.368M -$4.390M -$4.420M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$4.390M -$4.420M
YoY Change 670.18% -32.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0000886744
CY2017 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
11033000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-27916000
CY2017 dei Entity Registrant Name
EntityRegistrantName
GERON CORP
CY2017Q4 us-gaap Assets
Assets
110313000
CY2016Q4 us-gaap Assets
Assets
130249000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
503000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
225000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3385000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2843000
CY2017Q4 gern Collaborative Arrangement Accrued Collaboration Charges Current
CollaborativeArrangementAccruedCollaborationChargesCurrent
1702000
CY2016Q4 gern Collaborative Arrangement Accrued Collaboration Charges Current
CollaborativeArrangementAccruedCollaborationChargesCurrent
3367000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6516000
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
160000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
159000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1089684000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-985840000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-207000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
103797000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110313000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
475000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q2 dei Entity Public Float
EntityPublicFloat
438713000
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
160654027
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Trading Symbol
TradingSymbol
GERN
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12810000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
268000
CY2017Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
78351000
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
102035000
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
524000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
116112000
CY2017Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
14241000
CY2016Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
13954000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
926000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1434000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7869000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
17831000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17793000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16335000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
268000
CY2017Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
436000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
580000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
95970000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-154000
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18761000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-29255000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19287000
CY2017 us-gaap Operating Expenses
OperatingExpenses
30320000
CY2016 us-gaap Operating Expenses
OperatingExpenses
36808000
CY2015 us-gaap Operating Expenses
OperatingExpenses
36930000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-30646000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-559000
CY2016 us-gaap Interest And Other Income
InterestAndOtherIncome
1192000
CY2016 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
18047000
CY2017 us-gaap Interest And Other Income
InterestAndOtherIncome
1416000
CY2015 us-gaap Interest And Other Income
InterestAndOtherIncome
677000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1080198000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-957924000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
122380000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130249000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8245000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8144000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28070000
CY2017 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
32000
CY2017 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
77000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159158636
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159877239
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159877239
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159158636
CY2015 us-gaap Contracts Revenue
ContractsRevenue
35000000
CY2017 gern Licenses And Royalty Revenue
LicensesAndRoyaltyRevenue
1065000
CY2016 gern Licenses And Royalty Revenue
LicensesAndRoyaltyRevenue
6162000
CY2015 gern Licenses And Royalty Revenue
LicensesAndRoyaltyRevenue
1371000
CY2017 us-gaap Revenues
Revenues
1065000
CY2016 us-gaap Revenues
Revenues
6162000
CY2015 us-gaap Revenues
Revenues
36371000
CY2015 us-gaap Restructuring Charges
RestructuringCharges
1306000
CY2015 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
16000
CY2016 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
83000
CY2015 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
88000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-29537000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
46000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159224986
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159045644
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158036162
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159224986
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159045644
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162663894
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
160000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-129000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29377000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
130712000
CY2015 us-gaap Share Based Goods And Nonemployee Services Transaction Stockholders Equity
ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity
364000
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
881000
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1694000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8397000
CY2015 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
161000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
142126000
CY2016 us-gaap Share Based Goods And Nonemployee Services Transaction Stockholders Equity
ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity
156000
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1169000
CY2016 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
61000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1060000
CY2017 us-gaap Share Based Goods And Nonemployee Services Transaction Stockholders Equity
ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity
200000
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
51000
CY2017 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
114000
CY2015 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-1000
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-89000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
278000
CY2017 gern Increase Decrease In Accrued Collaboration Charges
IncreaseDecreaseInAccruedCollaborationCharges
-1665000
CY2016 gern Increase Decrease In Accrued Collaboration Charges
IncreaseDecreaseInAccruedCollaborationCharges
1039000
CY2015 gern Increase Decrease In Accrued Collaboration Charges
IncreaseDecreaseInAccruedCollaborationCharges
2328000
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
161000
CY2017 gern Increase Decrease In Accrued Interest Receivable Net And Other Receivables
IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
-39000
CY2016 gern Increase Decrease In Accrued Interest Receivable Net And Other Receivables
IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
-731000
CY2015 gern Increase Decrease In Accrued Interest Receivable Net And Other Receivables
IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
243000
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
56000
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-123000
CY2017 us-gaap Depreciation
Depreciation
76000
CY2016 us-gaap Depreciation
Depreciation
81000
CY2015 us-gaap Depreciation
Depreciation
56000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
16000
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-273000
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-552000
CY2015 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2098000
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
200000
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
156000
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
364000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
8144000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
8245000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
8397000
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
32000
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
61000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
90000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-35000000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16000
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
206459000
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
4242000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
122976000
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
100006000
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
129250000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24196000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1000
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42796000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
138054000
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
202381000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
22970000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8762000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
73000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1169000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2575000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1169000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2575000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3525000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8438000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-21548000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21248000
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
15021000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
92592000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
116042000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
54000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
107000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
115989000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
77168000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
66534000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
169000
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4627732
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14475616
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11352766
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9375851
CY2017 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P4Y
CY2017 gern Number Of Customers
NumberOfCustomers
2
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
15022000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
92798000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2017Q4 gern Cash And Cash Equivalents Unrealized Losses
CashAndCashEquivalentsUnrealizedLosses
1000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
210000
CY2017Q4 gern Number Of Financial Institutions
NumberOfFinancialInstitutions
4
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
822000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1391000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
720000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1208000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
272000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
350000
CY2017Q4 gern Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
516000
CY2016Q4 gern Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
723000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
138000
us-gaap Payments For Restructuring
PaymentsForRestructuring
988000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1435000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
678000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
699000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
58000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
691000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
708000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
878000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
97000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
13959000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
6944000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
42000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
10000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
91127000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
73478000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
211000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
107000
CY2017 gern Loss Contingency Triggering Event Employee Termination Without Cause Following Change Of Control Period
LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod
P12M
CY2017 gern Loss Contingency Triggering Event Period Following Change Of Control During Which No Comparable Employment Is Offered By Entity
LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity
P30D
CY2017 gern Loss Contingency Triggering Event Period Following Change Of Control Within Which Employee Resigns Due To Material Change In Terms Of Employment
LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment
P12M
CY2015Q3 gern Common Stock Aggregate Offering Price
CommonStockAggregateOfferingPrice
50000000
CY2015Q3 gern Maximum Commission Rate
MaximumCommissionRate
0.030
CY2017Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
614230
CY2017Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1060000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
9570535
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3484000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
72066
CY2017 gern Share Based Compensation Forfeitures And Expirations In Period Net
ShareBasedCompensationForfeituresAndExpirationsInPeriodNet
188258
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6202727
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19125287
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12500
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
188258
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22408529
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
17249032
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
22171142
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.15
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.19
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.41
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.99
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.03
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.96
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M26D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M25D
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
537893
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
30044457
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
187700000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
322200000
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-89400000
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9600000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2300000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017 gern Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Asset Change In Amount
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetChangeInAmount
102300000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y2M15D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2034000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2034000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2034000
CY2017Q4 us-gaap Share Price
SharePrice
1.80
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14074457
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11356232
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.99
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.98
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
15000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
595000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2398000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
493000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2205000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8144000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8245000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8397000
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8008000
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P26M
CY2013 gern Defined Contribution Plan Vesting Period Of Matching Contributions
DefinedContributionPlanVestingPeriodOfMatchingContributions
P4Y
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
280400000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
34300000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
29800000
CY2017Q4 gern Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
2500000
CY2016Q4 gern Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
300000
CY2017Q4 gern Deferred Tax Assets Capitalized License Fees
DeferredTaxAssetsCapitalizedLicenseFees
100000
CY2016Q4 gern Deferred Tax Assets Capitalized License Fees
DeferredTaxAssetsCapitalizedLicenseFees
200000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
8200000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
11500000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
232800000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
322200000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
232800000
CY2017Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
15900000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14700000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1200000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15900000
CY2017 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
-154000
CY2016 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
160000
CY2015 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
-129000
CY2017Q1 us-gaap Revenues
Revenues
537000
CY2017Q2 us-gaap Revenues
Revenues
174000
CY2017Q3 us-gaap Revenues
Revenues
163000
CY2017Q4 us-gaap Revenues
Revenues
191000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
8031000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
6905000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
7407000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
7977000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-7183000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-6405000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-6899000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-7429000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-8842000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-8637000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-3576000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-8482000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2016Q1 us-gaap Revenues
Revenues
749000
CY2016Q2 us-gaap Revenues
Revenues
211000
CY2016Q3 us-gaap Revenues
Revenues
5108000
CY2016Q4 us-gaap Revenues
Revenues
94000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
9826000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
9122000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
8985000
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
8875000

Files In Submission

Name View Source Status
0001564590-18-006051-index-headers.html Edgar Link pending
0001564590-18-006051-index.html Edgar Link pending
0001564590-18-006051.txt Edgar Link pending
0001564590-18-006051-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018031518270609210746.jpg Edgar Link pending
gern-10k_20171231.htm Edgar Link pending
gern-20171231.xml Edgar Link completed
gern-20171231.xsd Edgar Link pending
gern-20171231_cal.xml Edgar Link unprocessable
gern-20171231_def.xml Edgar Link unprocessable
gern-20171231_lab.xml Edgar Link unprocessable
gern-20171231_pre.xml Edgar Link unprocessable
gern-ex1031_572.htm Edgar Link pending
gern-ex121_11.htm Edgar Link pending
gern-ex231_10.htm Edgar Link pending
gern-ex311_9.htm Edgar Link pending
gern-ex312_8.htm Edgar Link pending
gern-ex321_7.htm Edgar Link pending
gern-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending